200 related articles for article (PubMed ID: 33757752)
1. Inhibition of the Notch signaling pathway attenuates progression of cell motility, metastasis, and epithelial-to-mesenchymal transition-like phenomena induced by low concentrations of cisplatin in osteosarcoma.
Dai G; Liu G; Zheng D; Song Q
Eur J Pharmacol; 2021 May; 899():174058. PubMed ID: 33757752
[TBL] [Abstract][Full Text] [Related]
2. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
[TBL] [Abstract][Full Text] [Related]
3. Apatinib inhibits migration and invasion as well as PD-L1 expression in osteosarcoma by targeting STAT3.
Zheng B; Ren T; Huang Y; Guo W
Biochem Biophys Res Commun; 2018 Jan; 495(2):1695-1701. PubMed ID: 29225166
[TBL] [Abstract][Full Text] [Related]
4. Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
Wang C; Zhou X; Li W; Li M; Tu T; Ba X; Wu Y; Huang Z; Fan G; Zhou G; Wu S; Zhao J; Zhang J; Chen J
Cancer Lett; 2017 Sep; 403():271-279. PubMed ID: 28642171
[TBL] [Abstract][Full Text] [Related]
5. Fibulin-3 promotes osteosarcoma invasion and metastasis by inducing epithelial to mesenchymal transition and activating the Wnt/β-catenin signaling pathway.
Wang S; Zhang D; Han S; Gao P; Liu C; Li J; Pan X
Sci Rep; 2017 Jul; 7(1):6215. PubMed ID: 28740094
[TBL] [Abstract][Full Text] [Related]
6. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.
Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W
Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910
[TBL] [Abstract][Full Text] [Related]
7. 3-Hydroxyflavone inhibits human osteosarcoma U2OS and 143B cells metastasis by affecting EMT and repressing u-PA/MMP-2 via FAK-Src to MEK/ERK and RhoA/MLC2 pathways and reduces 143B tumor growth in vivo.
Lu KH; Chen PN; Hsieh YH; Lin CY; Cheng FY; Chiu PC; Chu SC; Hsieh YS
Food Chem Toxicol; 2016 Nov; 97():177-186. PubMed ID: 27600294
[TBL] [Abstract][Full Text] [Related]
8. Glaucocalyxin A reverses EMT and TGF-β1-induced EMT by inhibiting TGF-β1/Smad2/3 signaling pathway in osteosarcoma.
Jiang X; Zhang Z; Song C; Deng H; Yang R; Zhou L; Sun Y; Zhang Q
Chem Biol Interact; 2019 Jul; 307():158-166. PubMed ID: 31059706
[TBL] [Abstract][Full Text] [Related]
9. miR-382 inhibits osteosarcoma metastasis and relapse by targeting Y box-binding protein 1.
Xu M; Jin H; Xu CX; Sun B; Song ZG; Bi WZ; Wang Y
Mol Ther; 2015 Jan; 23(1):89-98. PubMed ID: 25292190
[TBL] [Abstract][Full Text] [Related]
10. Osteosarcoma cell intrinsic PD-L2 signals promote invasion and metastasis via the RhoA-ROCK-LIMK2 and autophagy pathways.
Ren T; Zheng B; Huang Y; Wang S; Bao X; Liu K; Guo W
Cell Death Dis; 2019 Mar; 10(4):261. PubMed ID: 30886151
[TBL] [Abstract][Full Text] [Related]
11. Ezrin/NF-κB Pathway Regulates EGF-induced Epithelial-Mesenchymal Transition (EMT), Metastasis, and Progression of Osteosarcoma.
Liu P; Yang P; Zhang Z; Liu M; Hu S
Med Sci Monit; 2018 Apr; 24():2098-2108. PubMed ID: 29628496
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin selects for stem-like cells in osteosarcoma by activating Notch signaling.
Yu L; Fan Z; Fang S; Yang J; Gao T; Simões BM; Eyre R; Guo W; Clarke RB
Oncotarget; 2016 May; 7(22):33055-68. PubMed ID: 27102300
[TBL] [Abstract][Full Text] [Related]
13. Nitidine chloride suppresses epithelial-to-mesenchymal transition in osteosarcoma cell migration and invasion through Akt/GSK-3β/Snail signaling pathway.
Cheng Z; Guo Y; Yang Y; Kan J; Dai S; Helian M; Li B; Xu J; Liu C
Oncol Rep; 2016 Aug; 36(2):1023-9. PubMed ID: 27279040
[TBL] [Abstract][Full Text] [Related]
14. Micafungin exerts antitumor effect on breast cancer and osteosarcoma through preventing EMT in tumor cells in an USP7/AKT/GSK-3β pathway-dependent manner.
Wang QL; Wang L; Li QY; Li HY; Lin L; Wei D; Xu JY; Luo XJ
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4447-4459. PubMed ID: 38108838
[TBL] [Abstract][Full Text] [Related]
15. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
Zhang Y; Cheng H; Li W; Wu H; Yang Y
Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of tumor suppressing STF cDNA 3 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by the Wnt/GSK-3β/β-catenin/Snail signaling pathway.
Lv YF; Dai H; Yan GN; Meng G; Zhang X; Guo QN
Cancer Lett; 2016 Apr; 373(2):164-73. PubMed ID: 26845447
[TBL] [Abstract][Full Text] [Related]
17. Notch signaling is important for epithelial-mesenchymal transition induced by low concentrations of doxorubicin in osteosarcoma cell lines.
Yang J; Guo W; Wang L; Yu L; Mei H; Fang S; Chen A; Liu Y; Xia K; Liu G
Oncol Lett; 2017 Apr; 13(4):2260-2268. PubMed ID: 28454389
[TBL] [Abstract][Full Text] [Related]
18. Novel ADAM-17 inhibitor ZLDI-8 inhibits the proliferation and metastasis of chemo-resistant non-small-cell lung cancer by reversing Notch and epithelial mesenchymal transition in vitro and in vivo.
Lu HY; Zu YX; Jiang XW; Sun XT; Liu TY; Li RL; Wu Q; Zhang YS; Zhao QC
Pharmacol Res; 2019 Oct; 148():104406. PubMed ID: 31442576
[TBL] [Abstract][Full Text] [Related]
19. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
Zhang Y; Wang F; Wang L; Zhang Q
World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]